Intervention to Improve Driving Practices Among High-Risk Teen Drivers

Summary

The purpose of this study is to test the effects of an in-vehicle driving feedback technology, with and without parent communication training, on risky driving events, unsafe driving behaviors, and subsequent traffic violations among teens who have recently received a moving traffic violation.

Conditions

• Drive
• Recidivism
• Communication
• Feedback, Psychological

Interventions

COMBINATION_PRODUCT

In-vehicle device

The Azūga™ in-vehicle driving feedback technology, which consists of a pager-sized device plugged into the vehicle's on-board diagnostic port (installed in the teen's car) and a smartphone app (downloaded on the teen's smartphone), will be installed/downloaded. Three types of feedback will be provided to intervention teens: 1) Direct audio feedback from the installed device; 2) Push notification on the phone screen when a trip ends, 3) Detailed cumulative driving data; and 4) A customized biweekly driving summary report.

BEHAVIORAL

Parent Communication

An individualized virtual training in communication strategies about driving safety along with a booster session will be delivered by a traffic safety communication specialist to subjects in the Feedback and Parent Communication Group. Intervention parents in this group will also be provided with access to an online parent-teen safe driving communication guide, including includes three motivational interviewing technique demonstration videos and 26 safe driving lessons.

Sponsors & Collaborators

• University of Iowa

  collaborator OTHER

• Ohio State University

  collaborator OTHER

• University of Nebraska

  collaborator OTHER

• Ginger Yang

  lead OTHER

Principal Investigators

• Jingzhen (Ginger) Yang, PhD, MPH · Nationwide Children's Hospital

Study Design

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

16 Years

Max Age

17 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2020-09-28

Primary Completion

2024-12-31

Completion

2025-12-31

FDA Device

Yes

Countries

• United States

Study Locations